General MedicationsCAPSULEGeneric
POMALIDOMIDE
POMALIDOMIDE
Standard Dose
4MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview POMALIDOMIDE is listed in Drugs@FDA under application 210232 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient POMALIDOMIDE Form and strength CAPSULE - 4MG Sponsor SUN PHARMACEUTICAL INDUSTRIES LIMITED Submission history Latest submission status date: 2026-03-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview POMALIDOMIDE is listed in Drugs@FDA under application 210232 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient POMALIDOMIDE Form and strength CAPSULE - 4MG Sponsor SUN PHARMACEUTICAL INDUSTRIES LIMITED Submission history Latest submission status date: 2026-03-24 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.